Skip to main content
Top
Published in: Immunologic Research 1-3/2013

01-03-2013 | Immunology in Colorado

Redefining the major peanut allergens

Authors: Yonghua Zhuang, Stephen C. Dreskin

Published in: Immunologic Research | Issue 1-3/2013

Login to get access

Abstract

Food allergy has become a major public health concern in westernized countries, and allergic reactions to peanuts are particularly common and severe. Allergens are defined as antigens that elicit an IgE response, and most allergenic materials (e.g., pollens, danders, and foods) contain multiple allergenic proteins. This has led to the concept that there are “major” allergens and allergens of less importance. “Major allergens” have been defined as allergens that bind a large amount of IgE from the majority of patients and have biologic activity. However, the ability of an allergen to cross-link complexes of IgE and its high-affinity receptor FcεRI (IgE/FcεRI), which we have termed its allergic effector activity, does not correlate well with assays of IgE binding. To identify the proteins that are the most active allergens in peanuts, we and others have employed in vitro model assays of allergen-mediated cross-linking of IgE/FcεRI complexes and have demonstrated that the most potent allergens are not necessarily those that bind the most IgE. The importance of a specific allergen can be determined by measuring the allergic effector activity of that allergen following purification under non-denaturing conditions and by specifically removing the allergen from a complex allergenic extract either by chromatography or by specific immunodepletion. In our studies of peanut allergens, our laboratory has found that two related allergens, Ara h 2 and Ara h 6, together account for the majority of the effector activity in a crude peanut extract. Furthermore, murine studies demonstrated that Ara h 2 and Ara h 6 are not only the major elicitors of anaphylaxis in this system, but also can effectively desensitize peanut-allergic mice. As a result of these observations, we propose that the definition of a major allergen should be based on the potency of that allergen in assays of allergic effector activity and demonstration that removal of that allergen from an extract results in loss of potency. Using these criteria, Ara h 2 and Ara h 6 are the major peanut allergens.
Literature
1.
go back to reference Otsu K, Dreskin SC. Peanut allergy: an evolving clinical challenge. Discov Med. 2011;12(65):319–28.PubMed Otsu K, Dreskin SC. Peanut allergy: an evolving clinical challenge. Discov Med. 2011;12(65):319–28.PubMed
3.
go back to reference Sampson HA. Adverse reactions to foods. In: Middleton Jr E, Reed CE, Ellis EF, Adkinson Jr NF, Yunginger JW, Busse WW, editors. Allergy, principles and practice. St. Louis: Mosby; 1998. p. 1162–82. Sampson HA. Adverse reactions to foods. In: Middleton Jr E, Reed CE, Ellis EF, Adkinson Jr NF, Yunginger JW, Busse WW, editors. Allergy, principles and practice. St. Louis: Mosby; 1998. p. 1162–82.
7.
go back to reference Nowak-Wegrzyn A, Sampson HA. Future therapies for food allergies. J Allergy Clin Immunol. 2011;127(3):558–73.PubMedCrossRef Nowak-Wegrzyn A, Sampson HA. Future therapies for food allergies. J Allergy Clin Immunol. 2011;127(3):558–73.PubMedCrossRef
8.
go back to reference Lowenstein H. Quantitative immunoelectrophoretic methods as a tool for the analysis and isolation of allergens. Prog Allergy. 1978;25:1–62.PubMed Lowenstein H. Quantitative immunoelectrophoretic methods as a tool for the analysis and isolation of allergens. Prog Allergy. 1978;25:1–62.PubMed
9.
go back to reference Marsh DG, Goodfriend L, King TP, Lowenstein H, Platts-Mills TA. Allergen nomenclature. Bull World Health Organ. 1986;64(5):767–74.PubMed Marsh DG, Goodfriend L, King TP, Lowenstein H, Platts-Mills TA. Allergen nomenclature. Bull World Health Organ. 1986;64(5):767–74.PubMed
10.
go back to reference Chapman MD. Allergen nomenclature. In: Lockey RF, Bukantz SC, Bousquet J, editors. Allergens and allergen immunotherapy. New York: Marcel Dekker, Inc.; 2004. p. 51–64. Chapman MD. Allergen nomenclature. In: Lockey RF, Bukantz SC, Bousquet J, editors. Allergens and allergen immunotherapy. New York: Marcel Dekker, Inc.; 2004. p. 51–64.
11.
go back to reference King TP, Hoffman D, Lowenstein H, Marsh DG, Platts-Mills TA, Thomas W. Allergen nomenclature. Allergy. 1995;50(9):765–74.PubMedCrossRef King TP, Hoffman D, Lowenstein H, Marsh DG, Platts-Mills TA, Thomas W. Allergen nomenclature. Allergy. 1995;50(9):765–74.PubMedCrossRef
12.
go back to reference Chapman MD, Pomes A, Breiteneder H, Ferreira F. Nomenclature and structural biology of allergens. J Allergy Clin Immunol. 2007;119(2):414–20.PubMedCrossRef Chapman MD, Pomes A, Breiteneder H, Ferreira F. Nomenclature and structural biology of allergens. J Allergy Clin Immunol. 2007;119(2):414–20.PubMedCrossRef
13.
go back to reference Burks AW, Cockrell G, Stanley JS, Helm RM, Bannon GA. Recombinant peanut allergen Ara h I expression and IgE binding in patients with peanut hypersensitivity. J Clin Invest. 1995;96(4):1715–21.PubMedCrossRef Burks AW, Cockrell G, Stanley JS, Helm RM, Bannon GA. Recombinant peanut allergen Ara h I expression and IgE binding in patients with peanut hypersensitivity. J Clin Invest. 1995;96(4):1715–21.PubMedCrossRef
14.
go back to reference Stanley JS, King N, Burks AW, Huang SK, Sampson H, Cockrell G, et al. Identification and mutational analysis of the immunodominant IgE binding epitopes of the major peanut allergen Ara h 2. Arch Biochem Biophys. 1997;342(2):244–53.PubMedCrossRef Stanley JS, King N, Burks AW, Huang SK, Sampson H, Cockrell G, et al. Identification and mutational analysis of the immunodominant IgE binding epitopes of the major peanut allergen Ara h 2. Arch Biochem Biophys. 1997;342(2):244–53.PubMedCrossRef
15.
go back to reference Kleber-Janke T, Crameri R, Appenzeller U, Schlaak M, Becker WM. Selective cloning of peanut allergens, including profilin and 2S albumins, by phage display technology. Int Arch Allergy Immunol. 1999;119(4):265–74.PubMedCrossRef Kleber-Janke T, Crameri R, Appenzeller U, Schlaak M, Becker WM. Selective cloning of peanut allergens, including profilin and 2S albumins, by phage display technology. Int Arch Allergy Immunol. 1999;119(4):265–74.PubMedCrossRef
16.
go back to reference Rabjohn P, Helm EM, Stanley JS, West CM, Sampson HA, Burks AW, et al. Molecular cloning and epitope analysis of the peanut allergen Ara h 3. J Clin Invest. 1999;103(4):535–42.PubMedCrossRef Rabjohn P, Helm EM, Stanley JS, West CM, Sampson HA, Burks AW, et al. Molecular cloning and epitope analysis of the peanut allergen Ara h 3. J Clin Invest. 1999;103(4):535–42.PubMedCrossRef
17.
go back to reference Pons L, Chery C, Romano A, Namour F, Artesani MC, Gueant JL. The 18 kDa peanut oleosin is a candidate allergen for IgE-mediated reactions to peanuts. Allergy. 2002;57(Suppl 72):88–93.PubMedCrossRef Pons L, Chery C, Romano A, Namour F, Artesani MC, Gueant JL. The 18 kDa peanut oleosin is a candidate allergen for IgE-mediated reactions to peanuts. Allergy. 2002;57(Suppl 72):88–93.PubMedCrossRef
18.
go back to reference Mittag D, Akkerdaas J, Ballmer-Weber BK, Vogel L, Wensing M, Becker WM, et al. Ara h 8, a Bet v 1-homologous allergen from peanut, is a major allergen in patients with combined birch pollen and peanut allergy. J Allergy Clin Immunol. 2004;114(6):1410–7.PubMedCrossRef Mittag D, Akkerdaas J, Ballmer-Weber BK, Vogel L, Wensing M, Becker WM, et al. Ara h 8, a Bet v 1-homologous allergen from peanut, is a major allergen in patients with combined birch pollen and peanut allergy. J Allergy Clin Immunol. 2004;114(6):1410–7.PubMedCrossRef
19.
go back to reference Dodo H, Konan K, Viquez O. A genetic engineering strategy to eliminate peanut allergy. Curr Allergy Asthma Rep. 2005;5(1):67–73.PubMedCrossRef Dodo H, Konan K, Viquez O. A genetic engineering strategy to eliminate peanut allergy. Curr Allergy Asthma Rep. 2005;5(1):67–73.PubMedCrossRef
20.
go back to reference Scholl I, Boltz-Nitulescu G, Jensen-Jarolim E. Review of novel particulate antigen delivery systems with special focus on treatment of type I allergy. J Control Release. 2005;104(1):1–27.PubMedCrossRef Scholl I, Boltz-Nitulescu G, Jensen-Jarolim E. Review of novel particulate antigen delivery systems with special focus on treatment of type I allergy. J Control Release. 2005;104(1):1–27.PubMedCrossRef
21.
go back to reference Li XM. Beyond allergen avoidance: update on developing therapies for peanut allergy. Curr Opin Allergy Clin Immunol. 2005;5(3):287–92.PubMedCrossRef Li XM. Beyond allergen avoidance: update on developing therapies for peanut allergy. Curr Opin Allergy Clin Immunol. 2005;5(3):287–92.PubMedCrossRef
22.
go back to reference Astier C, Morisset M, Roitel O, Codreanu F, Jacquenet S, Franck P, et al. Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy. J Allergy Clin Immunol. 2006;118(1):250–6.PubMedCrossRef Astier C, Morisset M, Roitel O, Codreanu F, Jacquenet S, Franck P, et al. Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy. J Allergy Clin Immunol. 2006;118(1):250–6.PubMedCrossRef
23.
go back to reference van Ree R, Chapman MD, Ferreira F, Vieths S, Bryan D, Cromwell O, et al. The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification. Allergy. 2008;63(3):310–26.PubMedCrossRef van Ree R, Chapman MD, Ferreira F, Vieths S, Bryan D, Cromwell O, et al. The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification. Allergy. 2008;63(3):310–26.PubMedCrossRef
25.
go back to reference Moneret-Vautrin DA. Modifications of allergenicity linked to food technologies. Allerg Immunol (Paris). 1998;30(1):9–13. Moneret-Vautrin DA. Modifications of allergenicity linked to food technologies. Allerg Immunol (Paris). 1998;30(1):9–13.
26.
go back to reference Nelson HS, Lahr J, Rule R, Bock A, Leung D. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol. 1997;99(6 Pt 1):744–51.PubMedCrossRef Nelson HS, Lahr J, Rule R, Bock A, Leung D. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol. 1997;99(6 Pt 1):744–51.PubMedCrossRef
27.
go back to reference Li XM, Srivastava K, Grishin A, Huang CK, Schofield B, Burks W, et al. Persistent protective effect of heat-killed Escherichia coli producing “engineered,” recombinant peanut proteins in a murine model of peanut allergy. J Allergy Clin Immunol. 2003;112(1):159–67.PubMedCrossRef Li XM, Srivastava K, Grishin A, Huang CK, Schofield B, Burks W, et al. Persistent protective effect of heat-killed Escherichia coli producing “engineered,” recombinant peanut proteins in a murine model of peanut allergy. J Allergy Clin Immunol. 2003;112(1):159–67.PubMedCrossRef
28.
go back to reference Li XM, Srivastava K, Huleatt JW, Bottomly K, Burks AW, Sampson HA. Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model. J Immunol. 2003;170(6):3289–95.PubMed Li XM, Srivastava K, Huleatt JW, Bottomly K, Burks AW, Sampson HA. Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model. J Immunol. 2003;170(6):3289–95.PubMed
29.
go back to reference Srivastava KD, Kattan JD, Zou ZM, Li JH, Zhang L, Wallenstein S, et al. The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy. J Allergy Clin Immunol. 2005;115(1):171–8.PubMedCrossRef Srivastava KD, Kattan JD, Zou ZM, Li JH, Zhang L, Wallenstein S, et al. The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy. J Allergy Clin Immunol. 2005;115(1):171–8.PubMedCrossRef
30.
go back to reference Leung DY, Shanahan WR Jr, Li XM, Sampson HA. New approaches for the treatment of anaphylaxis. Novartis Found Symp. 2004;257:248–60.PubMedCrossRef Leung DY, Shanahan WR Jr, Li XM, Sampson HA. New approaches for the treatment of anaphylaxis. Novartis Found Symp. 2004;257:248–60.PubMedCrossRef
31.
go back to reference Scurlock AM, Burks AW. Peanut allergenicity. Ann Allergy Asthma Immunol. 2004;93(5 Suppl 3):S12–8.PubMedCrossRef Scurlock AM, Burks AW. Peanut allergenicity. Ann Allergy Asthma Immunol. 2004;93(5 Suppl 3):S12–8.PubMedCrossRef
32.
go back to reference Palmer GW, Dibbern DA, Burks AW, Bannon GA, Bock SA, Porterfield HS, et al. Comparative potency of Ara h 1 and Ara h 2 in immunochemical and functional assays of allergenicity. Clin Immunol. 2005;115:301–12.CrossRef Palmer GW, Dibbern DA, Burks AW, Bannon GA, Bock SA, Porterfield HS, et al. Comparative potency of Ara h 1 and Ara h 2 in immunochemical and functional assays of allergenicity. Clin Immunol. 2005;115:301–12.CrossRef
33.
go back to reference Breiteneder H, Mills EN. Molecular properties of food allergens. J Allergy Clin Immunol. 2005;115(1):14–23.PubMedCrossRef Breiteneder H, Mills EN. Molecular properties of food allergens. J Allergy Clin Immunol. 2005;115(1):14–23.PubMedCrossRef
34.
go back to reference Breiteneder H, Radauer C. A classification of plant food allergens. J Allergy Clin Immunol. 2004;113(5):821–30.PubMedCrossRef Breiteneder H, Radauer C. A classification of plant food allergens. J Allergy Clin Immunol. 2004;113(5):821–30.PubMedCrossRef
35.
go back to reference Jenkins JA, Griffiths-Jones S, Shewry PR, Breiteneder H, Mills EN. Structural relatedness of plant food allergens with specific reference to cross-reactive allergens: an in silico analysis. J Allergy Clin Immunol. 2005;115(1):163–70.PubMedCrossRef Jenkins JA, Griffiths-Jones S, Shewry PR, Breiteneder H, Mills EN. Structural relatedness of plant food allergens with specific reference to cross-reactive allergens: an in silico analysis. J Allergy Clin Immunol. 2005;115(1):163–70.PubMedCrossRef
36.
go back to reference Hoffmann-Sommergruber K, Mills EN. Food allergen protein families and their structural characteristics and application in component-resolved diagnosis: new data from the EuroPrevall project. Anal Bioanal Chem. 2009;395(1):25–35.PubMedCrossRef Hoffmann-Sommergruber K, Mills EN. Food allergen protein families and their structural characteristics and application in component-resolved diagnosis: new data from the EuroPrevall project. Anal Bioanal Chem. 2009;395(1):25–35.PubMedCrossRef
37.
go back to reference Burks AW, Shin D, Cockrell G, Stanley JS, Helm RM, Bannon GA. Mapping and mutational analysis of the IgE-binding epitopes on Ara h 1, a legume vicilin protein and a major allergen in peanut hypersensitivity. Eur J Biochem. 1997;245(2):334–9.PubMedCrossRef Burks AW, Shin D, Cockrell G, Stanley JS, Helm RM, Bannon GA. Mapping and mutational analysis of the IgE-binding epitopes on Ara h 1, a legume vicilin protein and a major allergen in peanut hypersensitivity. Eur J Biochem. 1997;245(2):334–9.PubMedCrossRef
38.
go back to reference Shin DS, Compadre CM, Maleki SJ, Kopper RA, Sampson H, Huang SK, et al. Biochemical and structural analysis of the IgE binding sites on ara h1, an abundant and highly allergenic peanut protein. J Biol Chem. 1998;273(22):13753–9.PubMedCrossRef Shin DS, Compadre CM, Maleki SJ, Kopper RA, Sampson H, Huang SK, et al. Biochemical and structural analysis of the IgE binding sites on ara h1, an abundant and highly allergenic peanut protein. J Biol Chem. 1998;273(22):13753–9.PubMedCrossRef
39.
go back to reference Maleki SJ, Kopper RA, Shin DS, Park CW, Compadre CM, Sampson H, et al. Structure of the major peanut allergen Ara h 1 may protect IgE-binding epitopes from degradation. J Immunol. 2000;164(11):5844–9.PubMed Maleki SJ, Kopper RA, Shin DS, Park CW, Compadre CM, Sampson H, et al. Structure of the major peanut allergen Ara h 1 may protect IgE-binding epitopes from degradation. J Immunol. 2000;164(11):5844–9.PubMed
40.
go back to reference Chatel JM, Bernard H, Orson FM. Isolation and characterization of two complete Ara h 2 isoforms cDNA. Int Arch Allergy Immunol. 2003;131(1):14–8.PubMedCrossRef Chatel JM, Bernard H, Orson FM. Isolation and characterization of two complete Ara h 2 isoforms cDNA. Int Arch Allergy Immunol. 2003;131(1):14–8.PubMedCrossRef
41.
go back to reference Hales BJ, Bosco A, Mills KL, Hazell LA, Loh R, Holt PG, et al. Isoforms of the major peanut allergen Ara h 2: IgE binding in children with peanut allergy. Int Arch Allergy Immunol. 2004;135(2):101–7.PubMedCrossRef Hales BJ, Bosco A, Mills KL, Hazell LA, Loh R, Holt PG, et al. Isoforms of the major peanut allergen Ara h 2: IgE binding in children with peanut allergy. Int Arch Allergy Immunol. 2004;135(2):101–7.PubMedCrossRef
42.
go back to reference Lehmann K, Schweimer K, Reese G, Randow S, Suhr M, Becker WM, et al. Structure and stability of 2S albumin-type peanut allergens: implications for the severity of peanut allergic reactions. Biochem J. 2006;395(3):463–72.PubMedCrossRef Lehmann K, Schweimer K, Reese G, Randow S, Suhr M, Becker WM, et al. Structure and stability of 2S albumin-type peanut allergens: implications for the severity of peanut allergic reactions. Biochem J. 2006;395(3):463–72.PubMedCrossRef
43.
go back to reference Koppelman SJ, Knol EF, Vlooswijk RA, Wensing M, Knulst AC, Hefle SL, et al. Peanut allergen Ara h 3: isolation from peanuts and biochemical characterization. Allergy. 2003;58(11):1144–51.PubMedCrossRef Koppelman SJ, Knol EF, Vlooswijk RA, Wensing M, Knulst AC, Hefle SL, et al. Peanut allergen Ara h 3: isolation from peanuts and biochemical characterization. Allergy. 2003;58(11):1144–51.PubMedCrossRef
44.
go back to reference Suhr M, Wicklein D, Lepp U, Becker WM. Isolation and characterization of natural Ara h 6: evidence for a further peanut allergen with putative clinical relevance based on resistance to pepsin digestion and heat. Mol Nutr Food Res. 2004;48(5):390–9.PubMedCrossRef Suhr M, Wicklein D, Lepp U, Becker WM. Isolation and characterization of natural Ara h 6: evidence for a further peanut allergen with putative clinical relevance based on resistance to pepsin digestion and heat. Mol Nutr Food Res. 2004;48(5):390–9.PubMedCrossRef
45.
go back to reference Koppelman SJ, de Jong GA, Laaper-Ertmann M, Peeters KA, Knulst AC, Hefle SL, et al. Purification and immunoglobulin E-binding properties of peanut allergen Ara h 6: evidence for cross-reactivity with Ara h 2. Clin Exp Allergy. 2005;35(4):490–7.PubMedCrossRef Koppelman SJ, de Jong GA, Laaper-Ertmann M, Peeters KA, Knulst AC, Hefle SL, et al. Purification and immunoglobulin E-binding properties of peanut allergen Ara h 6: evidence for cross-reactivity with Ara h 2. Clin Exp Allergy. 2005;35(4):490–7.PubMedCrossRef
46.
go back to reference Chen X, Wang Q, El-Mezayen R, Zhuang Y, Dreskin SC. Ara h 2 and Ara h 6 have similar allergic effector activity and are substantially redundant. Int Arch Allergy Immunol. 2012 (in press). Chen X, Wang Q, El-Mezayen R, Zhuang Y, Dreskin SC. Ara h 2 and Ara h 6 have similar allergic effector activity and are substantially redundant. Int Arch Allergy Immunol. 2012 (in press).
47.
go back to reference Krause S, Reese G, Randow S, Zennaro D, Quaratino D, Palazzo P, et al. Lipid transfer protein (Ara h 9) as a new peanut allergen relevant for a Mediterranean allergic population. J Allergy Clin Immunol. 2009;124(4):771–8.PubMedCrossRef Krause S, Reese G, Randow S, Zennaro D, Quaratino D, Palazzo P, et al. Lipid transfer protein (Ara h 9) as a new peanut allergen relevant for a Mediterranean allergic population. J Allergy Clin Immunol. 2009;124(4):771–8.PubMedCrossRef
48.
go back to reference Stevenson SE, Chu Y, Ozias-Akins P, Thelen JJ. Validation of gel-free, label-free quantitative proteomics approaches: applications for seed allergen profiling. J Proteomics. 2009;72(3):555–66.PubMedCrossRef Stevenson SE, Chu Y, Ozias-Akins P, Thelen JJ. Validation of gel-free, label-free quantitative proteomics approaches: applications for seed allergen profiling. J Proteomics. 2009;72(3):555–66.PubMedCrossRef
49.
go back to reference Nicolaou N, Custovic A. Molecular diagnosis of peanut and legume allergy. Curr Opin Allergy Clin Immunol. 2011;11(3):222–8.PubMedCrossRef Nicolaou N, Custovic A. Molecular diagnosis of peanut and legume allergy. Curr Opin Allergy Clin Immunol. 2011;11(3):222–8.PubMedCrossRef
50.
go back to reference Burks AW, Williams LW, Connaughton C, Cockrell G, O’Brien TJ, Helm RM. Identification and characterization of a second major peanut allergen, Ara h II, with use of the sera of patients with atopic dermatitis and positive peanut challenge. J Allergy Clin Immunol. 1992;90(6 Pt 1):962–9.PubMedCrossRef Burks AW, Williams LW, Connaughton C, Cockrell G, O’Brien TJ, Helm RM. Identification and characterization of a second major peanut allergen, Ara h II, with use of the sera of patients with atopic dermatitis and positive peanut challenge. J Allergy Clin Immunol. 1992;90(6 Pt 1):962–9.PubMedCrossRef
52.
go back to reference Schmitt DA, Cheng H, Maleki SJ, Burks AW. Competitive inhibition ELISA for quantification of Ara h 1 and Ara h 2, the major allergens of peanuts. J AOAC Int. 2004;87(6):1492–7.PubMed Schmitt DA, Cheng H, Maleki SJ, Burks AW. Competitive inhibition ELISA for quantification of Ara h 1 and Ara h 2, the major allergens of peanuts. J AOAC Int. 2004;87(6):1492–7.PubMed
53.
go back to reference Shreffler WG, Beyer K, Chu TH, Burks AW, Sampson HA. Microarray immunoassay: association of clinical history, in vitro IgE function, and heterogeneity of allergenic peanut epitopes. J Allergy Clin Immunol. 2004;113(4):776–82.PubMedCrossRef Shreffler WG, Beyer K, Chu TH, Burks AW, Sampson HA. Microarray immunoassay: association of clinical history, in vitro IgE function, and heterogeneity of allergenic peanut epitopes. J Allergy Clin Immunol. 2004;113(4):776–82.PubMedCrossRef
54.
go back to reference Shreffler WG, Lencer DA, Bardina L, Sampson HA. IgE and IgG4 epitope mapping by microarray immunoassay reveals the diversity of immune response to the peanut allergen, Ara h 2. J Allergy Clin Immunol. 2005;116(4):893–9.PubMedCrossRef Shreffler WG, Lencer DA, Bardina L, Sampson HA. IgE and IgG4 epitope mapping by microarray immunoassay reveals the diversity of immune response to the peanut allergen, Ara h 2. J Allergy Clin Immunol. 2005;116(4):893–9.PubMedCrossRef
55.
go back to reference Koppelman SJ, Wensing M, Ertmann M, Knulst AC, Knol EF. Relevance of Ara h1, Ara h2 and Ara h3 in peanut-allergic patients, as determined by immunoglobulin E Western blotting, basophil-histamine release and intracutaneous testing: Ara h2 is the most important peanut allergen. Clin Exp Allergy. 2004;34(4):583–90.PubMedCrossRef Koppelman SJ, Wensing M, Ertmann M, Knulst AC, Knol EF. Relevance of Ara h1, Ara h2 and Ara h3 in peanut-allergic patients, as determined by immunoglobulin E Western blotting, basophil-histamine release and intracutaneous testing: Ara h2 is the most important peanut allergen. Clin Exp Allergy. 2004;34(4):583–90.PubMedCrossRef
56.
go back to reference Dreskin SC, Thomas GW, Dale SN, Heasley LE. Isoforms of Jun kinase are differentially expressed and activated in human monocyte/macrophage (THP-1) cells. J Immunol. 2001;166(9):5646–53.PubMed Dreskin SC, Thomas GW, Dale SN, Heasley LE. Isoforms of Jun kinase are differentially expressed and activated in human monocyte/macrophage (THP-1) cells. J Immunol. 2001;166(9):5646–53.PubMed
57.
go back to reference Valenta R, Almo S, Ball T, Dolecek C, Steinberger P, Laffer S, et al. The immunoglobulin E-allergen interaction: a target for therapy of type I allergic diseases. Int Arch Allergy Immunol. 1998;116(3):167–76.PubMedCrossRef Valenta R, Almo S, Ball T, Dolecek C, Steinberger P, Laffer S, et al. The immunoglobulin E-allergen interaction: a target for therapy of type I allergic diseases. Int Arch Allergy Immunol. 1998;116(3):167–76.PubMedCrossRef
58.
59.
go back to reference Yunginger JW, Ahlstedt S, Eggleston PA, Homburger HA, Nelson HS, Ownby DR, et al. Quantitative IgE antibody assays in allergic diseases. J Allergy Clin Immunol. 2000;105(6 Pt 1):1077–84.PubMedCrossRef Yunginger JW, Ahlstedt S, Eggleston PA, Homburger HA, Nelson HS, Ownby DR, et al. Quantitative IgE antibody assays in allergic diseases. J Allergy Clin Immunol. 2000;105(6 Pt 1):1077–84.PubMedCrossRef
60.
go back to reference Caraballo L, Puerta L, Jimenez S, Martinez B, Mercado D, Avjiouglu A, et al. Cloning and IgE binding of a recombinant allergen from the mite Blomia tropicalis, homologous with fatty acid-binding proteins. Int Arch Allergy Immunol. 1997;112(4):341–7.PubMedCrossRef Caraballo L, Puerta L, Jimenez S, Martinez B, Mercado D, Avjiouglu A, et al. Cloning and IgE binding of a recombinant allergen from the mite Blomia tropicalis, homologous with fatty acid-binding proteins. Int Arch Allergy Immunol. 1997;112(4):341–7.PubMedCrossRef
61.
go back to reference Sampson HA, Ho DG. Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents. J Allergy Clin Immunol. 1997;100(4):444–51.PubMedCrossRef Sampson HA, Ho DG. Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents. J Allergy Clin Immunol. 1997;100(4):444–51.PubMedCrossRef
62.
go back to reference Dang TD, Tang M, Choo S, Licciardi PV, Koplin JJ, Martin PE, et al. Increasing the accuracy of peanut allergy diagnosis by using Ara h 2. J Allergy Clin Immunol. 2012;129(4):1056–63.PubMedCrossRef Dang TD, Tang M, Choo S, Licciardi PV, Koplin JJ, Martin PE, et al. Increasing the accuracy of peanut allergy diagnosis by using Ara h 2. J Allergy Clin Immunol. 2012;129(4):1056–63.PubMedCrossRef
63.
go back to reference Gleich GJ, Larson JB, Jones RT, Baer H. Measurement of the potency of allergy extracts by their inhibitory capacities in the radioallergosorbent test. J Allergy Clin Immunol. 1974;53(3):158–69.PubMedCrossRef Gleich GJ, Larson JB, Jones RT, Baer H. Measurement of the potency of allergy extracts by their inhibitory capacities in the radioallergosorbent test. J Allergy Clin Immunol. 1974;53(3):158–69.PubMedCrossRef
64.
go back to reference Stehbens WE. Koch’s postulates and experimental atherosclerosis. Med Hypotheses. 1991;35(4):288–92.PubMedCrossRef Stehbens WE. Koch’s postulates and experimental atherosclerosis. Med Hypotheses. 1991;35(4):288–92.PubMedCrossRef
65.
go back to reference Inglis TJ. Principia aetiologica: taking causality beyond Koch’s postulates. J Med Microbiol. 2007;56(Pt 11):1419–22.PubMedCrossRef Inglis TJ. Principia aetiologica: taking causality beyond Koch’s postulates. J Med Microbiol. 2007;56(Pt 11):1419–22.PubMedCrossRef
66.
go back to reference Fitch F, Lancki D, Havran W. Koch’s postulates and the molecular biology of T-cell function. Immunol Today. 1988;9(2):41–3.PubMedCrossRef Fitch F, Lancki D, Havran W. Koch’s postulates and the molecular biology of T-cell function. Immunol Today. 1988;9(2):41–3.PubMedCrossRef
67.
go back to reference Moxon ER. Microbes, molecules and man. The Mitchell lecture 1992. J R Coll Phys Lond. 1993;27(2):169–74. Moxon ER. Microbes, molecules and man. The Mitchell lecture 1992. J R Coll Phys Lond. 1993;27(2):169–74.
68.
go back to reference de Groot H, van Swieten P, van Leeuwen J, Lind P, Aalberse RC. Monoclonal antibodies to the major feline allergen Fel d I. I. Serologic and biologic activity of affinity-purified Fel d I and of Fel d I-depleted extract. J Allergy Clin Immunol. 1988;82(5 Pt 1):778–86.PubMed de Groot H, van Swieten P, van Leeuwen J, Lind P, Aalberse RC. Monoclonal antibodies to the major feline allergen Fel d I. I. Serologic and biologic activity of affinity-purified Fel d I and of Fel d I-depleted extract. J Allergy Clin Immunol. 1988;82(5 Pt 1):778–86.PubMed
69.
go back to reference Lombardero M, Quirce S, Duffort O, Barber D, Carpizo J, Chamorro MJ, et al. Monoclonal antibodies against Olea europaea major allergen: allergenic activity of affinity-purified allergen and depleted extract and development of a radioimmunoassay for the quantitation of the allergen. J Allergy Clin Immunol. 1992;89(4):884–94.PubMedCrossRef Lombardero M, Quirce S, Duffort O, Barber D, Carpizo J, Chamorro MJ, et al. Monoclonal antibodies against Olea europaea major allergen: allergenic activity of affinity-purified allergen and depleted extract and development of a radioimmunoassay for the quantitation of the allergen. J Allergy Clin Immunol. 1992;89(4):884–94.PubMedCrossRef
70.
go back to reference Urisu A, Ando H, Morita Y, Wada E, Yasaki T, Yamada K, et al. Allergenic activity of heated and ovomucoid-depleted egg white. J Allergy Clin Immunol. 1997;100(2):171–6.PubMedCrossRef Urisu A, Ando H, Morita Y, Wada E, Yasaki T, Yamada K, et al. Allergenic activity of heated and ovomucoid-depleted egg white. J Allergy Clin Immunol. 1997;100(2):171–6.PubMedCrossRef
71.
go back to reference van der Zee JS, van Swieten P, Jansen HM, Aalberse RC. Skin tests and histamine release with P1-depleted Dermatophagoides pteronyssinus body extracts and purified P1. J Allergy Clin Immunol. 1988;81(5 Pt 1):884–96.PubMed van der Zee JS, van Swieten P, Jansen HM, Aalberse RC. Skin tests and histamine release with P1-depleted Dermatophagoides pteronyssinus body extracts and purified P1. J Allergy Clin Immunol. 1988;81(5 Pt 1):884–96.PubMed
72.
go back to reference Norman PS, Winkenwerder WL, Lichtenstein LM. Immunotherapy of hay fever with ragweed antigen E: comparisons with whole pollen extract and placebos. J Allergy. 1968;42(2):93–108.PubMedCrossRef Norman PS, Winkenwerder WL, Lichtenstein LM. Immunotherapy of hay fever with ragweed antigen E: comparisons with whole pollen extract and placebos. J Allergy. 1968;42(2):93–108.PubMedCrossRef
73.
go back to reference Witteman AM, Stapel SO, Perdok GJ, Sjamsoedin DH, Jansen HM, Aalberse RC, et al. The relationship between RAST and skin test results in patients with asthma or rhinitis: a quantitative study with purified major allergens. J Allergy Clin Immunol. 1996;97(1 Pt 1):16–25.PubMedCrossRef Witteman AM, Stapel SO, Perdok GJ, Sjamsoedin DH, Jansen HM, Aalberse RC, et al. The relationship between RAST and skin test results in patients with asthma or rhinitis: a quantitative study with purified major allergens. J Allergy Clin Immunol. 1996;97(1 Pt 1):16–25.PubMedCrossRef
74.
go back to reference Wiegand TW, Williams PB, Dreskin SC, Jouvin MH, Kinet JP, Tasset D. High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc epsilon receptor I. J Immunol. 1996;157(1):221–30.PubMed Wiegand TW, Williams PB, Dreskin SC, Jouvin MH, Kinet JP, Tasset D. High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc epsilon receptor I. J Immunol. 1996;157(1):221–30.PubMed
75.
go back to reference Dibbern DJ, Palmer G, Williams P, Bock S, Dreskin S. RBL cells expressiing Human FcεRI are a sensitive tool for exploring functional IgE-allergen interactions. J Immunol Methods. 2003;274:37–45.PubMedCrossRef Dibbern DJ, Palmer G, Williams P, Bock S, Dreskin S. RBL cells expressiing Human FcεRI are a sensitive tool for exploring functional IgE-allergen interactions. J Immunol Methods. 2003;274:37–45.PubMedCrossRef
76.
go back to reference Porterfield HS, Murray KS, Schlichting DG, Chen X, Hansen KC, Duncan MW, et al. Effector activity of peanut allergens: a critical role for Ara h 2, Ara h 6, and their variants. Clin Exp Allergy. 2009;39(7):1099–108.PubMedCrossRef Porterfield HS, Murray KS, Schlichting DG, Chen X, Hansen KC, Duncan MW, et al. Effector activity of peanut allergens: a critical role for Ara h 2, Ara h 6, and their variants. Clin Exp Allergy. 2009;39(7):1099–108.PubMedCrossRef
77.
go back to reference Chen X, Zhuang Y, Wang Q, Moutsoglou D, Ruiz G, Yen SE, et al. Analysis of the effector activity of Ara h 2 and Ara h 6 by selective depletion from a crude peanut extract. J Immunol Methods. 2011;372(1–2):65–70.PubMedCrossRef Chen X, Zhuang Y, Wang Q, Moutsoglou D, Ruiz G, Yen SE, et al. Analysis of the effector activity of Ara h 2 and Ara h 6 by selective depletion from a crude peanut extract. J Immunol Methods. 2011;372(1–2):65–70.PubMedCrossRef
78.
go back to reference McDermott RA, Porterfield HS, El-Mezayan R, Schlichting D, Hansen KC, Duncan MW, et al. Contribution of Ara h 2 to peanut-specific immunoglobulin E-mediated, cell activation. Clin Exp Allergy. 2007;37:752–63.PubMedCrossRef McDermott RA, Porterfield HS, El-Mezayan R, Schlichting D, Hansen KC, Duncan MW, et al. Contribution of Ara h 2 to peanut-specific immunoglobulin E-mediated, cell activation. Clin Exp Allergy. 2007;37:752–63.PubMedCrossRef
79.
go back to reference Ladics GS, van Bilsen JH, Brouwer HM, Vogel L, Vieths S, Knippels LM. Assessment of three human FcepsilonRI-transfected RBL cell-lines for identifying IgE induced degranulation utilizing peanut-allergic patient sera and peanut protein extract. Regul Toxicol Pharmacol. 2008;51(3):288–94.PubMedCrossRef Ladics GS, van Bilsen JH, Brouwer HM, Vogel L, Vieths S, Knippels LM. Assessment of three human FcepsilonRI-transfected RBL cell-lines for identifying IgE induced degranulation utilizing peanut-allergic patient sera and peanut protein extract. Regul Toxicol Pharmacol. 2008;51(3):288–94.PubMedCrossRef
80.
go back to reference Saito H, Ebisawa M, Tachimoto H, Shichijo M, Fukagawa K, Matsumoto K, et al. Selective growth of human mast cells induced by steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells. J Immunol. 1996;157(1):343–50.PubMed Saito H, Ebisawa M, Tachimoto H, Shichijo M, Fukagawa K, Matsumoto K, et al. Selective growth of human mast cells induced by steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells. J Immunol. 1996;157(1):343–50.PubMed
81.
go back to reference Kepley CL, Youssef L, Andrews RP, Wilson BS, Oliver JM. Syk deficiency in nonreleaser basophils. J Allergy Clin Immunol. 1999;104(2 Pt 1):279–84.PubMedCrossRef Kepley CL, Youssef L, Andrews RP, Wilson BS, Oliver JM. Syk deficiency in nonreleaser basophils. J Allergy Clin Immunol. 1999;104(2 Pt 1):279–84.PubMedCrossRef
82.
go back to reference Ebo DG, Hagendorens MM, Bridts CH, Schuerwegh AJ, De Clerck LS, Stevens WJ. In vitro allergy diagnosis: should we follow the flow? Clin Exp Allergy. 2004;34(3):332–9.PubMedCrossRef Ebo DG, Hagendorens MM, Bridts CH, Schuerwegh AJ, De Clerck LS, Stevens WJ. In vitro allergy diagnosis: should we follow the flow? Clin Exp Allergy. 2004;34(3):332–9.PubMedCrossRef
83.
go back to reference Budde IK, de Heer PG, Natter S, Mahler V, van der Zee JS, Valenta R, et al. Studies on the association between immunoglobulin E autoreactivity and immunoglobulin E-dependent histamine-releasing factors. Immunology. 2002;107(2):243–51.PubMedCrossRef Budde IK, de Heer PG, Natter S, Mahler V, van der Zee JS, Valenta R, et al. Studies on the association between immunoglobulin E autoreactivity and immunoglobulin E-dependent histamine-releasing factors. Immunology. 2002;107(2):243–51.PubMedCrossRef
84.
go back to reference Li XM, Serebrisky D, Lee SY, Huang CK, Bardina L, Schofield BH, et al. A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses. J Allergy Clin Immunol. 2000;106(1 Pt 1):150–8.PubMedCrossRef Li XM, Serebrisky D, Lee SY, Huang CK, Bardina L, Schofield BH, et al. A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses. J Allergy Clin Immunol. 2000;106(1 Pt 1):150–8.PubMedCrossRef
85.
go back to reference Blanc F, Adel-Patient K, Drumare MF, Paty E, Wal JM, Bernard H. Capacity of purified peanut allergens to induce degranulation in a functional in vitro assay: Ara h 2 and Ara h 6 are the most efficient elicitors. Clin Exp Allergy. 2009;39(8):1277–85.PubMedCrossRef Blanc F, Adel-Patient K, Drumare MF, Paty E, Wal JM, Bernard H. Capacity of purified peanut allergens to induce degranulation in a functional in vitro assay: Ara h 2 and Ara h 6 are the most efficient elicitors. Clin Exp Allergy. 2009;39(8):1277–85.PubMedCrossRef
86.
go back to reference Peeters KA, Koppelman SJ, van Hoffen E, van der Tas CW, den Hartog Jager CF, Penninks AH, et al. Does skin prick test reactivity to purified allergens correlate with clinical severity of peanut allergy? Clin Exp Allergy. 2007;37(1):108–15.PubMedCrossRef Peeters KA, Koppelman SJ, van Hoffen E, van der Tas CW, den Hartog Jager CF, Penninks AH, et al. Does skin prick test reactivity to purified allergens correlate with clinical severity of peanut allergy? Clin Exp Allergy. 2007;37(1):108–15.PubMedCrossRef
87.
go back to reference Kulis M, Chen X, Lew J, Wang Q, Patel O, Murray KS et al. The 2S albumin allergens of Arachis hypogaea, Ara h 2 and Ara h 6, are the major elicitors of anaphylaxis and can effectively desensitize peanut-allergic mice. Clin Exp Allergy. 2012;42(2):326–36. Kulis M, Chen X, Lew J, Wang Q, Patel O, Murray KS et al. The 2S albumin allergens of Arachis hypogaea, Ara h 2 and Ara h 6, are the major elicitors of anaphylaxis and can effectively desensitize peanut-allergic mice. Clin Exp Allergy. 2012;42(2):326–36.
88.
go back to reference Krause S, Latendorf T, Schmidt H, Darcan-Nicolaisen Y, Reese G, Petersen A, et al. Peanut varieties with reduced Ara h 1 content indicating no reduced allergenicity. Mol Nutr Food Res. 2010;54(3):381–7.PubMedCrossRef Krause S, Latendorf T, Schmidt H, Darcan-Nicolaisen Y, Reese G, Petersen A, et al. Peanut varieties with reduced Ara h 1 content indicating no reduced allergenicity. Mol Nutr Food Res. 2010;54(3):381–7.PubMedCrossRef
89.
go back to reference McDermott RA, Porterfield HS, El-Mezayan R, Dreskin SC. Crude peanut extracts depleted of Ara h 2 retain the ability to cross-link IgE from peanut allergic subjects. J Allergy Clin Immuol. 2005;115(2):S37.CrossRef McDermott RA, Porterfield HS, El-Mezayan R, Dreskin SC. Crude peanut extracts depleted of Ara h 2 retain the ability to cross-link IgE from peanut allergic subjects. J Allergy Clin Immuol. 2005;115(2):S37.CrossRef
Metadata
Title
Redefining the major peanut allergens
Authors
Yonghua Zhuang
Stephen C. Dreskin
Publication date
01-03-2013
Publisher
Springer-Verlag
Published in
Immunologic Research / Issue 1-3/2013
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-012-8355-x

Other articles of this Issue 1-3/2013

Immunologic Research 1-3/2013 Go to the issue